Fast Five Quiz: Gastric Cancer Management

Elwyn C. Cabebe, MD


April 06, 2022

According to the ESMO guidelines, pre- and postoperative chemotherapy with a platinum and fluoropyrimidine combination is recommended for patients with stage IB or higher resectable gastric cancer; capecitabine-containing regimens can also be suggested.

Second-line chemotherapy options include irinotecan and docetaxel or paclitaxel.

In HER2-positive disease, recommended chemotherapy is with trastuzumab plus cisplatin and either 5-fluorouracil or capecitabine.

In HER2-negative disease, combination regimens on the basis of a platinum-fluoropyrimidine doublet are generally used; triplet regimens are controversial, but the addition of an anthracycline (eg, epirubicin) has demonstrated benefit.

Learn more about gastric cancer treatment guidelines.

Editor's Recommendations


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.